A multistage theory of age-specific acceleration in human mortality

<p>Abstract</p> <p>Background</p> <p>Humans die at an increasing rate until late in life, when mortality rates level off. The causes of the late-life mortality plateau have been debated extensively over the past few years. Here, I examine mortality patterns separately f...

Full description

Bibliographic Details
Main Author: Frank Steven A
Format: Article
Language:English
Published: BMC 2004-07-01
Series:BMC Biology
Online Access:http://www.biomedcentral.com/1741-7007/2/16
_version_ 1811275972095246336
author Frank Steven A
author_facet Frank Steven A
author_sort Frank Steven A
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Humans die at an increasing rate until late in life, when mortality rates level off. The causes of the late-life mortality plateau have been debated extensively over the past few years. Here, I examine mortality patterns separately for each of the leading causes of death. The different causes of death show distinct mortality patterns, providing some clues about the varying acceleration of mortality at different ages.</p> <p>Results</p> <p>I examine mortality patterns by first plotting the data of mortality rate versus age on a log-log scale. The slope of the age-specific mortality rate at each age is the age-specific acceleration of mortality. About one-half of total deaths have causes with similar shapes for the age-specific acceleration of mortality: a steady rise in acceleration from midlife until a well-defined peak at 80 years, followed by a nearly linear decline in acceleration. This first group of causes includes heart disease, cerebrovascular disease, and accidental deaths. A second group, accounting for about one-third of all deaths, follows a different pattern of age-specific acceleration. These diseases show an approximately linear rise in acceleration to a peak at 35–45 years of age, followed by a steep and steady decline in acceleration for the remainder of life. This second group includes cancer, chronic respiratory diseases, and liver disease. I develop a multistage model of disease progression to explain the observed patterns of mortality acceleration.</p> <p>Conclusions</p> <p>A multistage model of disease progression can explain both the early-life increase and late-life decrease in mortality acceleration. An early-life rise in acceleration may be caused by increasing rates of transition between stages as individuals grow older. The late-life decline in acceleration may be caused by progression through earlier stages, leaving only a few stages remaining for older individuals.</p>
first_indexed 2024-04-12T23:48:15Z
format Article
id doaj.art-89c949c93d904c9dac863506054344a9
institution Directory Open Access Journal
issn 1741-7007
language English
last_indexed 2024-04-12T23:48:15Z
publishDate 2004-07-01
publisher BMC
record_format Article
series BMC Biology
spelling doaj.art-89c949c93d904c9dac863506054344a92022-12-22T03:11:48ZengBMCBMC Biology1741-70072004-07-01211610.1186/1741-7007-2-16A multistage theory of age-specific acceleration in human mortalityFrank Steven A<p>Abstract</p> <p>Background</p> <p>Humans die at an increasing rate until late in life, when mortality rates level off. The causes of the late-life mortality plateau have been debated extensively over the past few years. Here, I examine mortality patterns separately for each of the leading causes of death. The different causes of death show distinct mortality patterns, providing some clues about the varying acceleration of mortality at different ages.</p> <p>Results</p> <p>I examine mortality patterns by first plotting the data of mortality rate versus age on a log-log scale. The slope of the age-specific mortality rate at each age is the age-specific acceleration of mortality. About one-half of total deaths have causes with similar shapes for the age-specific acceleration of mortality: a steady rise in acceleration from midlife until a well-defined peak at 80 years, followed by a nearly linear decline in acceleration. This first group of causes includes heart disease, cerebrovascular disease, and accidental deaths. A second group, accounting for about one-third of all deaths, follows a different pattern of age-specific acceleration. These diseases show an approximately linear rise in acceleration to a peak at 35–45 years of age, followed by a steep and steady decline in acceleration for the remainder of life. This second group includes cancer, chronic respiratory diseases, and liver disease. I develop a multistage model of disease progression to explain the observed patterns of mortality acceleration.</p> <p>Conclusions</p> <p>A multistage model of disease progression can explain both the early-life increase and late-life decrease in mortality acceleration. An early-life rise in acceleration may be caused by increasing rates of transition between stages as individuals grow older. The late-life decline in acceleration may be caused by progression through earlier stages, leaving only a few stages remaining for older individuals.</p>http://www.biomedcentral.com/1741-7007/2/16
spellingShingle Frank Steven A
A multistage theory of age-specific acceleration in human mortality
BMC Biology
title A multistage theory of age-specific acceleration in human mortality
title_full A multistage theory of age-specific acceleration in human mortality
title_fullStr A multistage theory of age-specific acceleration in human mortality
title_full_unstemmed A multistage theory of age-specific acceleration in human mortality
title_short A multistage theory of age-specific acceleration in human mortality
title_sort multistage theory of age specific acceleration in human mortality
url http://www.biomedcentral.com/1741-7007/2/16
work_keys_str_mv AT frankstevena amultistagetheoryofagespecificaccelerationinhumanmortality
AT frankstevena multistagetheoryofagespecificaccelerationinhumanmortality